Access to HIV Treatment — Raising the Bar

The global effort to ensure access to antiretroviral therapy for millions of people is one of the greatest success stories in the history of public health. In just a decade, access to life-saving HIV treatment in developing countries has increased more than forty-fold, with 9.7 million people in low- and middle-income countries accessing treatment in 2012, according to anew report from WHO, UNICEF, and UNAIDS.

Antiretroviral therapy saves lives, improves quality of life, and lifts communities and economies, enabling people to once again work, go to school, care for their families, and participate in society. Every day, treatment access and other investments are helping us get closer to an end of the AIDS epidemic.

Michel SidibÂŽ
Executive Director of the Joint United
Nations Programme on HIV/AIDS
Read More

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below